LIFE SCIENCES
Solutions to support the digital transformation of Life Sciences organisations. Our solutions help simplify complex process and deliver more efficient operations.
The move towards value-based healthcare and the convergence between healthcare and life sciences industries are impacting current paradigms, shifting from human driven drug screening and development to machine learning and AI, from consumable therapies to data analytics and gamification, from mass market therapeutics to precision medicine, from in person episodic care delivery to video and home monitoring and diagnostics.
Life sciences organisations have a pressing need for real-world evidence across their value chain, to improve decision making and deliver patient-centric strategies that lead to better health outcomes. However, organisations are challenged with gathering actionable insights at the speed needed to effectively bring innovation and new therapies to life.
Dedalus serves as a key bridge connecting Patients, Healthcare Providers and the Life Sciences industry. With an extensive network of over 6000 hospitals and 540+ million patient records, we facilitate innovative treatments and provide much-needed revenue to affiliated hospitals. Patient data in Electronic Health Records (EHRs) is fully anonymized, sharing only secure, anonymized statistical data in a secure research environment. Life sciences organizations can conduct feasibility, statistical analysis, retrospective digital studies, and express an interest in recruiting identified specific patient cohorts. This collaboration drives medical research, delivering new therapies while supporting hospitals. Dedalus plays a crucial role in advancing healthcare through secure data sharing and industry partnerships.
The move towards value-based healthcare and the convergence between healthcare and life sciences industries are impacting current paradigms, shifting from human driven drug screening and development to machine learning and AI, from consumable therapies to data analytics and gamification, from mass market therapeutics to precision medicine, from in person episodic care delivery to video and home monitoring and diagnostics.
Life sciences organisations have a pressing need for real-world evidence across their value chain, to improve decision making and deliver patient-centric strategies that lead to better health outcomes. However, organisations are challenged with gathering actionable insights at the speed needed to effectively bring innovation and new therapies to life.
Dedalus serves as a key bridge connecting Patients, Healthcare Providers and the Life Sciences industry. With an extensive network of over 6000 hospitals and 540+ million patient records, we facilitate innovative treatments and provide much-needed revenue to affiliated hospitals. Patient data in Electronic Health Records (EHRs) is fully anonymized, sharing only secure, anonymized statistical data in a secure research environment. Life sciences organizations can conduct feasibility, statistical analysis, retrospective digital studies, and express an interest in recruiting identified specific patient cohorts. This collaboration drives medical research, delivering new therapies while supporting hospitals. Dedalus plays a crucial role in advancing healthcare through secure data sharing and industry partnerships.
The move towards value-based healthcare and the convergence between healthcare and life sciences industries are impacting current paradigms, shifting from human driven drug screening and development to machine learning and AI, from consumable therapies to data analytics and gamification, from mass market therapeutics to precision medicine, from in person episodic care delivery to video and home monitoring and diagnostics.
Life sciences organisations have a pressing need for real-world evidence across their value chain, to improve decision making and deliver patient-centric strategies that lead to better health outcomes. However, organisations are challenged with gathering actionable insights at the speed needed to effectively bring innovation and new therapies to life.
Dedalus serves as a key bridge connecting Patients, Healthcare Providers and the Life Sciences industry. With an extensive network of over 6000 hospitals and 540+ million patient records, we facilitate innovative treatments and provide much-needed revenue to affiliated hospitals. Patient data in Electronic Health Records (EHRs) is fully anonymized, sharing only secure, anonymized statistical data in a secure research environment. Life sciences organizations can conduct feasibility, statistical analysis, retrospective digital studies, and express an interest in recruiting identified specific patient cohorts. This collaboration drives medical research, delivering new therapies while supporting hospitals. Dedalus plays a crucial role in advancing healthcare through secure data sharing and industry partnerships.
The move towards value-based healthcare and the convergence between healthcare and life sciences industries are impacting current paradigms, shifting from human driven drug screening and development to machine learning and AI, from consumable therapies to data analytics and gamification, from mass market therapeutics to precision medicine, from in person episodic care delivery to video and home monitoring and diagnostics.
Life sciences organisations have a pressing need for real-world evidence across their value chain, to improve decision making and deliver patient-centric strategies that lead to better health outcomes. However, organisations are challenged with gathering actionable insights at the speed needed to effectively bring innovation and new therapies to life.
Dedalus serves as a key bridge connecting Patients, Healthcare Providers and the Life Sciences industry. With an extensive network of over 6000 hospitals and 540+ million patient records, we facilitate innovative treatments and provide much-needed revenue to affiliated hospitals. Patient data in Electronic Health Records (EHRs) is fully anonymized, sharing only secure, anonymized statistical data in a secure research environment. Life sciences organizations can conduct feasibility, statistical analysis, retrospective digital studies, and express an interest in recruiting identified specific patient cohorts. This collaboration drives medical research, delivering new therapies while supporting hospitals. Dedalus plays a crucial role in advancing healthcare through secure data sharing and industry partnerships.
The move towards value-based healthcare and the convergence between healthcare and life sciences industries are impacting current paradigms, shifting from human driven drug screening and development to machine learning and AI, from consumable therapies to data analytics and gamification, from mass market therapeutics to precision medicine, from in person episodic care delivery to video and home monitoring and diagnostics.
Life sciences organisations have a pressing need for real-world evidence across their value chain, to improve decision making and deliver patient-centric strategies that lead to better health outcomes. However, organisations are challenged with gathering actionable insights at the speed needed to effectively bring innovation and new therapies to life.
Dedalus serves as a key bridge connecting Patients, Healthcare Providers and the Life Sciences industry. With an extensive network of over 6000 hospitals and 540+ million patient records, we facilitate innovative treatments and provide much-needed revenue to affiliated hospitals. Patient data in Electronic Health Records (EHRs) is fully anonymized, sharing only secure, anonymized statistical data in a secure research environment. Life sciences organizations can conduct feasibility, statistical analysis, retrospective digital studies, and express an interest in recruiting identified specific patient cohorts. This collaboration drives medical research, delivering new therapies while supporting hospitals. Dedalus plays a crucial role in advancing healthcare through secure data sharing and industry partnerships.
The move towards value-based healthcare and the convergence between healthcare and life sciences industries are impacting current paradigms, shifting from human driven drug screening and development to machine learning and AI, from consumable therapies to data analytics and gamification, from mass market therapeutics to precision medicine, from in person episodic care delivery to video and home monitoring and diagnostics.
Life sciences organisations have a pressing need for real-world evidence across their value chain, to improve decision making and deliver patient-centric strategies that lead to better health outcomes. However, organisations are challenged with gathering actionable insights at the speed needed to effectively bring innovation and new therapies to life.
Dedalus serves as a key bridge connecting Patients, Healthcare Providers and the Life Sciences industry. With an extensive network of over 6000 hospitals and 540+ million patient records, we facilitate innovative treatments and provide much-needed revenue to affiliated hospitals. Patient data in Electronic Health Records (EHRs) is fully anonymized, sharing only secure, anonymized statistical data in a secure research environment. Life sciences organizations can conduct feasibility, statistical analysis, retrospective digital studies, and express an interest in recruiting identified specific patient cohorts. This collaboration drives medical research, delivering new therapies while supporting hospitals. Dedalus plays a crucial role in advancing healthcare through secure data sharing and industry partnerships.